The loss of a parliamentary majority by Theresa May’s Conservative party has cast doubt on the future of Brexit, with its new political partners and its own ministers said to be calling for
The last 18 months has seen groundbreaking cancer immunotherapies, led by BMS’s Opdivo and Merck Sharp & Dohme’s Keytruda hit the UK market, with both rapidly adding multiple indication
In a new white paper from the World Without Disease initiative, a 2024 update is provided of the current endeavours and developments that have occurred since inaugural discussions last year